Philipp Hendrix1,2, Itay Melamed1, Malie Collins3, Noah Lieberman3, Vaibhav Sharma3, Oded Goren1, Ramin Zand4, Clemens M Schirmer1,5, Christoph J Griessenauer6,7,8. 1. Department of Neurosurgery, Geisinger, Danville, PA, USA. 2. Department of Neurosurgery, Saarland University Medical Center, Homburg, Germany. 3. Geisinger Commonwealth School of Medicine, Scranton, PA, USA. 4. Department of Neurology, Geisinger, Danville, PA, USA. 5. Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria. 6. Department of Neurosurgery, Geisinger, Danville, PA, USA. christoph.griessenauer@gmail.com. 7. Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria. christoph.griessenauer@gmail.com. 8. Department of Neurosurgery, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria. christoph.griessenauer@gmail.com.
Abstract
BACKGROUND: Mechanical thrombectomy (MT) for large vessel occlusion (LVO) ischemic stroke is a safe and effective treatment modality. The National Institute of Health Stroke Scale (NIHSS) 24 h after MT (24 h-NIHSS) was shown to serve as the strongest surrogate for 90-day functional outcome. Here, we seek to externally validate 24 h-NIHSS as predictor for 90-day functional outcome and explore additional variables in this context. METHODS: Patients treated for anterior LVO between February 2016 and August 2020 with premorbid mRS < 3 were included. Receiver operating characteristics were used to compare different NIHSS-related surrogates, such as baseline (B) NIHSS, 24 h-NIHSS, Δ‑NIHSS and percent (%) change NIHSS to predict favorable function outcome (mRS 0-2). Additional analysis was performed to assess predictors associated with poor outcome despite reaching the best predictor threshold. RESULTS: A total of 337 eligible cases were identified. The 24 h-NIHSS outperformed B‑NIHSS, Δ‑NIHSS, and %‑NIHSS in terms of 90-day mRS 0-2 prediction. A 24-NIHSS ≤ 8 was identified as the optimal binary threshold. Multivariable analysis demonstrated that 24-NIHSS ≤ 8 and younger patient age were independently associated with mRS 0-2. Despite achieving 24 h-NIHSS ≤ 8, 23/143 (16.1%) cases experienced poor outcome (mRS 4-6). Older age, higher baseline NIHSS, coexisting chronic kidney disease, and longer hospital stay were independent predictors for poor outcome despite achieving 24 h-NIHSS ≤ 8. CONCLUSION: An NIHSS of 8 or less 24 h after MT was validated to serve as an independent, strong surrogate for favorable functional outcome; however, cofactors such as older age, higher baseline NIHSS and coexisting comorbidities appear to mitigate this clinical adjunct.
BACKGROUND: Mechanical thrombectomy (MT) for large vessel occlusion (LVO) ischemic stroke is a safe and effective treatment modality. The National Institute of Health Stroke Scale (NIHSS) 24 h after MT (24 h-NIHSS) was shown to serve as the strongest surrogate for 90-day functional outcome. Here, we seek to externally validate 24 h-NIHSS as predictor for 90-day functional outcome and explore additional variables in this context. METHODS: Patients treated for anterior LVO between February 2016 and August 2020 with premorbid mRS < 3 were included. Receiver operating characteristics were used to compare different NIHSS-related surrogates, such as baseline (B) NIHSS, 24 h-NIHSS, Δ‑NIHSS and percent (%) change NIHSS to predict favorable function outcome (mRS 0-2). Additional analysis was performed to assess predictors associated with poor outcome despite reaching the best predictor threshold. RESULTS: A total of 337 eligible cases were identified. The 24 h-NIHSS outperformed B‑NIHSS, Δ‑NIHSS, and %‑NIHSS in terms of 90-day mRS 0-2 prediction. A 24-NIHSS ≤ 8 was identified as the optimal binary threshold. Multivariable analysis demonstrated that 24-NIHSS ≤ 8 and younger patient age were independently associated with mRS 0-2. Despite achieving 24 h-NIHSS ≤ 8, 23/143 (16.1%) cases experienced poor outcome (mRS 4-6). Older age, higher baseline NIHSS, coexisting chronic kidney disease, and longer hospital stay were independent predictors for poor outcome despite achieving 24 h-NIHSS ≤ 8. CONCLUSION: An NIHSS of 8 or less 24 h after MT was validated to serve as an independent, strong surrogate for favorable functional outcome; however, cofactors such as older age, higher baseline NIHSS and coexisting comorbidities appear to mitigate this clinical adjunct.
Authors: Tatiana Kharitonova; Robert Mikulik; Risto O Roine; Lauri Soinne; Niaz Ahmed; Nils Wahlgren Journal: Stroke Date: 2011-04-21 Impact factor: 7.914
Authors: William J Tate; Laura C Polding; Stephanie Kemp; Michael Mlynash; Jeremy J Heit; Michael P Marks; Gregory W Albers; Maarten G Lansberg Journal: Stroke Date: 2019-07-10 Impact factor: 7.914
Authors: Nils H Petersen; Sreeja Kodali; Can Meng; Fangyong Li; Cindy Khanh Nguyen; Krithika U Peshwe; Sumita Strander; Andrew Silverman; Alexandra Kimmel; Anson Wang; Mohammad Anadani; Eyad Almallouhi; Alejandro M Spiotta; Joon-Tae Kim; James A Giles; Salah G Keyrouz; Mudassir Farooqui; Cynthia Zevallos; Ilko L Maier; Marios-Nikos Psychogios; Jan Liman; Nolwenn Riou-Comte; Sébastien Richard; Benjamin Gory; Stacey Quintero Wolfe; Patrick A Brown; Kyle M Fargen; Eva A Mistry; Hiba Fakhri; Akshitkumar M Mistry; Ka-Ho Wong; Adam de Havenon; Fábio A Nascimento; Peter Kan; Charles Matouk; Santiago Ortega-Gutiérrez; Kevin N Sheth Journal: Stroke Date: 2021-11-16 Impact factor: 7.914
Authors: Mirja M Wirtz; Philipp Hendrix; Oded Goren; Lisa A Beckett; Heather R Dicristina; Clemens M Schirmer; Shamsher Dalal; Gregory Weiner; Paul M Foreman; Ramin Zand; Christoph J Griessenauer Journal: J Neurosurg Date: 2019-12-20 Impact factor: 5.115